Home / NEUP / Company Profile

Neuphoria Therapeutics Inc

NEUP | Healthcare | NASDAQ
🌐 Website 📊 Reports 📈 Financials
$4.27
+0.00 (+0.00%)

Key Metrics

Market Cap
$7.94M
P/E Ratio
-1.06
EPS
$-4.02
Beta
N/A
Dividend Yield
N/A
ROE
-7.94%
Current Ratio
2.72

Company Information

Industry
Medical Pharmaceuticals

About Neuphoria Therapeutics Inc

Neuphoria Therapeutics Inc is a clinicalstage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders The company was founded on December 23 2024 and is headquartered in Burlington MA

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-11-14 $-4.41 $-0.55 701.8%
2025-09-29 $-5.79 $-0.56 933.9%
2025-05-20 $6.55 $-0.47 +-1,493.6%
2025-03-17 $-0.01 $-2.01 +-99.6%

Financial Ratios (TTM)

Gross Margin
86.49%
Operating Margin
-12,166.00%
Net Margin
-4,076.08%
ROA
-1,383.66%
Price to Book
0.77
Price to Sales
0.86